SHPH
Shuttle Pharmaceuticals Holdings, Inc.
Set alert
- YTD
- -71.39%
- 1 year
- -83.11%
- Open
- 5.35
- Prev close
- 5.23
- Mkt cap
- 24.54M
- Vol
- 20.48K
- Avg vol
- 120.11K
- EPS
- -16.87
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.80
- High
- 5.42
- Forward P/E
- 0.00
- Beta
- 0.74
- Short ratio
- 0.25
- Inst. own
- 1.81%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.06
- 200-d avg
- 2.42
- 1y target
- 0.00
Key statistics
- Market cap
- 2.62M
- Enterprise value
- 1.20M
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.35
- EPS (TTM)
- -4.25
- Beta
- 0.74
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -2.49M
- Total cash
- 2.34M
- Total debt
- 1.16M
- Return on equity
- -186.00%
- Shares outstanding
- 3.66M
- Short % of float
- 27.91%
- 50-day average
- 1.06
- 200-day average
- 2.42
Analyst view
Consensus: none
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
About Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers . The company is based in Gaithersburg, Maryland.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- Website
- shuttlepharma.com
News
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- Shuttle Pharmaceuticals Q2 EPS $(3.10) Up From $(32.90) YoY
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- 12 Health Care Stocks Moving In Thursday's After-Market Session
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- 12 Health Care Stocks Moving In Monday's Intraday Session
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- 12 Health Care Stocks Moving In Friday's Intraday Session
- 12 Health Care Stocks Moving In Monday's After-Market Session
- 12 Health Care Stocks Moving In Friday's Intraday Session
Your note
Sign in to keep a note on SHPH — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ADKINS WILLIAM H | Founder | Sale | Dec 28, 2022 | 184,071 |
| BROWN MILTON | Director | Sale | Dec 12, 2023 | 1,094,610 |
| DRITSCHILO ANATOLY | Chief Executive Officer | Stock Gift | Aug 13, 2023 | 0 |
| DRITSCHILO PETER | President | Sale | Dec 28, 2022 | 6,560 |
| JACOBS BETTE | Director | Sale | Dec 12, 2023 | 27,064 |
| JUNG MIRA | Officer | Sale | Dec 28, 2022 | 1,071,390 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| HRT Financial LP | 0.71% | 25,866 | 18.49K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.11% | 3,858 | 2.76K | Sep 29, 2024 |
| Federation Des Caisses Desjardins Du Quebec | 0.00% | 63 | 45 | Sep 29, 2024 |
| Bank of America Corporation | 0.00% | 9 | 6 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.09% | 3,151 | 2.25K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.02% | 616 | 440 | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.01% | 501 | 358 | Oct 30, 2024 |